FindTrial
Sign In

Rational administration of vancomycin in patients with acute kidney injury

Rational administration of vancomycin in patients with acute kidney injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101501
Enrollment
Unknown
Registered
2025-04-25
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Pre-medication creatinine group:None
current creatinine group:None

Sponsors

The First People's Hospital of Zhangjiagang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with AKI; 2. Age >=18 years old; 3. Indication for intravenous vancomycin; 4. No serious cardiopulmonary disease and normal liver function.

Exclusion criteria

Exclusion criteria: 1. Persons who cannot be treated completely for some reason during the course; 2. Those who are allergic to vancomycin; 3. Patients undergoing hemodialysis.

Design outcomes

Primary

MeasureTime frame
Compliance rate of trough blood concentration of vancomycin;—

Secondary

MeasureTime frame
28-day mortality;—

Countries

China

Contacts

Public ContactBinbin Yu

The First People's Hospital of Zhangjiagang

yubinbin1109@126.com+86 159 6239 5630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026